Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Thu, 07th Jun 2012 13:59

Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cyan's announcement at the end of May that the first Cyan metering partner in India had received a formal request from the TNEB. Airline company Aer Lingus Group has said that its flown passenger load factor in May 2012 increased by 2.9 percentage points on May 2011 to 76.2%. Short haul flown load factor was 73.8%, an increase of 0.9 points on May 2011, with capacity decreasing by 1.6%. Long haul flown load factor was 81.5%, a year-on-year (y/y) increase of 7.4 points, with capacity increasing by 0.5%. The company's flown passengers in May totalled 882,000, a y/y increase of 0.1% compared. Short haul flown passengers in May 2012 were 793,000, a y/y decrease of 1.1%, while long haul flown passengers in May 2012 were 89,000, an increase of 12.7% on May 2011. Aer Lingus Regional's total flown passenger numbers in May 2012 were 88,000, an increase of 33.3% compared to May 2011. Mobile Tornado Group, a provider of instant communication mobile applications to the enterprise market, posted a rise in revenues from £1.4m to £2.0m, while pre-tax loses narrowed to £1.2m (2010: £1.6m). The cost of sales doubled to £0.7m, while basic and diluted losses per share came in at 0.59p, compared to 0.85p the previous year. The company achieved increased sales activity during the year, up 43%, and believes that market within which it operates is increasingly receptive to the proposition it has developed. ANGLE, a technology commercialisation company, has said that its partner, ORIGIO, has received a bid from Cooper Companies, which values ORIGIO at $189m, including debt. Directors and shareholders owning a total of 46% in the company have signed irrevocable undertakings to accept the Cooper offer. The offer represents a 73% premium to the closing price of the shares on June 1st. Cooper has said the combined business will be ranked number one in the IVF market with a 39% market share. If the offer is completed, ORIGIO will continue under the same executive management team and name, operating as an indirect wholly-owned subsidiary of Cooper.Sareum Holdings has conditionally raised £25,000 (before expenses) after placing just over 2.9m shares at 0.85p each. The placing follows a placing made on Wednesday, which raised £0.23m. The company believes that both placings offer the most effective way of providing capital to accelerate its drug discovery programme and to provide working capital for the company. It is expected that the shares will begin trading on June 11th. The company now has around 1.5bn shares in issue.
More News
23 Apr 2021 12:17

Sareum shares rise after improved interim results, research progress

Sareum shares rise after improved interim results, research progress

Read more
16 Feb 2021 13:56

IN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform

IN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform

Read more
7 Jan 2021 12:52

Sareum gets approval for US patent application

(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office has now formally approved its patent application, number 16/351,620.

Read more
7 Jan 2021 10:51

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

Read more
7 Jan 2021 09:53

Sareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor

Sareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor

Read more
16 Dec 2020 22:00

IN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate

IN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate

Read more
14 Dec 2020 12:27

Sareum Shares Surge 30% After Study Results Support Covid-19 Programme

Sareum Shares Surge 30% After Study Results Support Covid-19 Programme

Read more
8 Dec 2020 15:51

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
3 Dec 2020 15:45

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

Read more
3 Dec 2020 12:19

Sareum Holdings secures grant for Covid-19 treatment project

(Sharecast News) - Specialist drug development company Sareum Holdings announced on Thursday that the grant offer letter from UK Research and Innovation (UKRI) had now been received and approved.

Read more
12 Nov 2020 19:17

UK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb

UK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb

Read more
27 Oct 2020 15:16

IN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant

IN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant

Read more
13 Oct 2020 13:54

IN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses

IN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses

Read more
8 Oct 2020 19:54

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

Read more
8 Oct 2020 15:50

Sareum to get US patent on SDC-1802 programme

(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent on an invention associated with its proprietary 'SDC-1802 TYK2/JAK1 Kinase Inhibitor Programme'.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.